Pharma Profit Dilemma

The conversation highlights the tension between pharmaceutical companies' desire to develop curative treatments and the financial pressures from Wall Street. While companies may aim to create lasting solutions, the market often favors ongoing treatments that ensure continuous revenue. This raises questions about how the industry balances innovation with economic sustainability.